metaLead logo — metaLead revolutionizes the way medicine treats metal-relate...

metaLead

metaLead revolutionizes the way medicine treats metal-related diseases.

Founded 2023 Switzerland Zurich, Switzerland 3 employees Convertible Note Total: $650.00K Biopharma, Biotechnology

General Information

Company Name metaLead
Founded Year 2023
Location Switzerland Zurich, Switzerland
Employees 3
Industries Biopharma, Biotechnology
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with metaLead. To contact metaLead, visit metalead.ch.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does metaLead compare?

A PDF of metaLead and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting metaLead soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About metaLead

metaLead is a Switzerland-based startup that aims to revolutionize the treatment of metal-related diseases. The company, founded in 2023, operates within the Biopharma and Biotechnology industries, focusing on developing innovative solutions to safely and effectively address metal-related health issues. Recently, the company received a significant $500.00K investment in the form of a Convertible Note from BioInnovation Institute on 31 August 2023. This investment marks a significant milestone for metaLead as they continue their mission to advance healthcare through their pioneering medical solutions.

Business keywords: medicine, metal-related diseases, treatment, disease management

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $500.00K 1
BioInnovation Institute
31 Aug 2023
Grant Fr.150.00K 1
Venture Kick
09 Mar 2023

metaLead Alternatives & Competitors

View All Alternatives
metaLead vs

Pioneering the future of infection management with precision-targeted biotherapeutics to combat anti...

Grant
Biopharma, Biotechnology
metaLead vs

On a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin...

Post-IPO Equity
187 employees
Biopharma, Biotechnology
metaLead vs

Pioneering the future of genetic medicine with the power to rewrite the genome and cure diseases at...

21 employees
Biopharma, Biotechnology

FAQ About metaLead

metaLead revolutionizes the way medicine treats metal-related diseases.
metaLead was founded in 2023.
metaLead is headquartered in Zurich, Switzerland.
metaLead operates in Biopharma and Biotechnology. Its work centres on medicine, metal-related diseases, treatment and disease management.
metaLead has approximately 3 employees.
metaLead has completed 2 funding rounds, raising a total of $650.00K. The latest funding stage is Convertible Note.
Top alternatives and competitors to metaLead include Felix Biotechnology, DBV Technologies, Tessera Therapeutics, Athersys, Promedior. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
metaLead and Felix Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for metaLead, https://bouncewatch.com/company/metalead, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes